Enfermedades Cerebrovasculares e HTA: rol del tratamiento antihipertensivo crónico (página 2)

22. The ONTARGET Investigators .
Telmisartan , ramipril or both in patients at high risk for
vascular events . N Eng J Med 2008 ; 358:1547-59 .

23. Staessen JA , Fagard R ,
Lutgard T , y col for the Systolic Hypertension in Europe
(Syst-Eur ) Trial Investigators : randomized double-blind
comparision of placebo and active treatment for older
patients with isolated systolic hypertension . Lancet 1997 ,
350 :757-764 .

24. Julius S , Kieldsen SE , Weber
M , et al . Outcomes in hypertensive patients at high
cardiovascular risk treated with regimen based on valsartan
or amlodipine : the VALUE randomized trial et al . Lancet
2004 ; 363:2022-2051 .

25. Hansson L , Zanchetti A ,
Carruthers SG , Dahlof B , Elmfeldt D , Menard J , et al for
the HOT Study Group . Effects of intensive blood pressure
lowering and low-dose aspirin in patients with hypertension :
principal results of the Hypertension Optimal Trial ( HOT )
randomized trial . Lancet 1998 ; 351:1755-1762 .

26. Ghong L , Zhang W , Zhu Y ,
Zhu J , Kong D , Page V et al . Shangai Trial of Nifedipine
in the Elderly ( STONE ) . J Hypertens 1996 ; 14:1237-1245
.

27. Tvomilehto J , Rasthyte D ,
Birkenhager WH . Effects of calcium-channel blockade in older
patients with diabetes and systolic hypertension .N Eng J Med
1999 ; 540: 677-684.

28. Dargie H , Krumholz HM . Los
betabloqueantes reducen el riesgo de mortalidad tras
insuficiencia cardiaca leve . Lancet ( ed-esp ) 1999 ;
353:9-13 .

29. Lindholm LH , Carlberg B ,
Samuelson O . Should betablockers remain first choice in the
treatment of primary hypertension ? . Lancet 2005 ;
1545-1553

30. Schiffrin E , Dey LY ,
Larochelle P . Progressive improvement in the estructure of
resistance arteries of hypertensive patients after 2 years of
treatment with an angiotensin I-converting inhibitor .
Comparision with effect of a beta-blocker . Am J Hypertens
1995; 8:229-236 .

31. Waisman G , Atenolo en
hypertension ¿ es una sabia eleccion ? Evid actual
pract ambul 2005 ; 8:71 .

32. Psaty BM , Lumley T , Furberg
CD , Schellenbaum G , Pahor M , Alderman MH , et al . Health
outcomes associated with various antihypertensive therapies
used as first time agents : a network meta-analysis JAMA 2003
; 289:2534-2544 .

33. Remme WJ , Torp-Pedersen C ,
Cleland JGF et al . Carvedilol protects better against
vascular events than metoprolol in heart failure . Results
from COMET . J Am Coll Cardiol 2007 ; 49:963-971 .